Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma

Inclusion Criteria: * Patients with newly histologically confirmed non-keratinizing carcinoma (according to WHO histological type) * No evidence of distant metastasis (M0) * Performance status: PS 0\~2 * Receive standard treatment * Able to read and understand the questionnaires * Not exhibiting overt psychopathology * Willing to give feedback to physicians and written informed consent was obtained Exclusion Criteria: * WHO type keratinizing squamous cell carcinoma or basaloid squamous cell carcinoma. * Treatment with palliative intent. * Prior malignancy (except adequately treated carcinoma in-situ of the cervix or basal/squamous cell carcinoma of the skin) * Previous chemotherapy or radiotherapy (except non-melanomatous skin cancers outside the intended RT treatment volume) * Patient is pregnant or lactating * Severe intercurrent disease